Statins: How Cholesterol-Lowering Medicines Work & Stay Safe

If you have had a blood test showing high LDL ("bad") cholesterol, a doctor has very likely mentioned a statin. Yet in Bangladesh, most people who should be taking one are not. A 2025 analysis of the nationally representative WHO-STEPS 2018 survey found that only about 6.9% of Bangladeshi adults who qualified for a statin under WHO primary-prevention criteria were actually taking one — and even among people who already had a stroke or heart attack, only 23.5% were on treatment. That gap matters, because statins are one of the few medicines proven to directly cut the risk of a future heart attack or stroke, not just lower a number on a lab report.

This guide explains, in plain language, what statins actually do inside the body, who genuinely needs one, how to take them correctly, what the real risks are (and are not), and when to involve a doctor.

What statins are and how they actually work

Statins are a class of medicines — including atorvastatin, rosuvastatin, and simvastatin, all sold in Bangladesh under various generic and brand names — that lower the level of LDL cholesterol circulating in the blood. They work by blocking an enzyme in the liver called HMG-CoA reductase, which the liver needs to manufacture cholesterol on its own.

When this enzyme is blocked, two things happen:

• The liver produces less cholesterol internally.
• In response, liver cells pull more LDL receptors to their surface, which actively removes extra LDL cholesterol from the bloodstream and clears it away.

Depending on the specific statin and dose, this combination lowers LDL cholesterol by roughly 35% to 55%. Beyond the cholesterol-lowering effect itself, research also points to secondary ("pleiotropic") benefits — statins appear to calm inflammation inside blood vessel walls and help stabilize the fatty plaques that can otherwise rupture and trigger a heart attack. This is one reason statins reduce cardiovascular risk by more than cholesterol numbers alone would predict.

Who actually needs a statin?

Statins are not meant for everyone with a slightly elevated cholesterol reading. Clinical guidelines from the American College of Cardiology and American Heart Association (ACC/AHA) — which most Bangladeshi cardiologists use as a reference alongside local and WHO guidance — generally identify four groups of adults as candidates:

• People who already have cardiovascular disease — a prior heart attack, stroke, or diagnosed blockage in an artery ("secondary prevention"). This group benefits the most and should almost never stop treatment without medical supervision.
• People with very high LDL cholesterol — generally 190 mg/dL or above, which often points to an inherited condition called familial hypercholesterolemia.
• Adults aged 40–75 with diabetes, even if their LDL is only moderately elevated, because diabetes itself sharply raises cardiovascular risk.
• Adults with an elevated estimated 10-year cardiovascular risk, calculated from a formula that factors in age, blood pressure, cholesterol, smoking status, and diabetes.

Newer 2026 guideline work has shifted this risk calculation further: it introduces an updated risk calculator (replacing the older Pooled Cohort Equations and removing race as an input), adds a 30-year risk estimate alongside the traditional 10-year one for younger adults, and sets clearer LDL goals by risk category — generally under 100 mg/dL for intermediate-risk patients, under 70 mg/dL for high-risk patients, and under 55 mg/dL for very-high-risk patients with existing cardiovascular disease. A one-time measurement of a related particle called lipoprotein(a), or Lp(a), is also increasingly recommended to refine risk, especially when heart disease runs in the family.

None of these numbers are meant for self-diagnosis. The right starting point is a fasting lipid profile and a conversation with a doctor about your overall risk — not your LDL number in isolation.

Statins available in Bangladesh

All three major statins are widely available in Bangladesh, as both generics and branded products, and are generally affordable:

• Atorvastatin — sold under brand names such as G-Atorvastatin and others, commonly in 10mg, 20mg, and 40mg strengths.
• Rosuvastatin — sold under brand names including RTV, Rosu, Ambar, Creva, Resva, and Rocovas, usually in 5mg, 10mg, 20mg, and 40mg strengths.
• Simvastatin — sold under brand names including Zostin, Avastin, Simacor, and Simvatin, typically in 10mg and 20mg strengths.

Prices for a single tablet are generally low (often only a few taka), but all of these are prescription-only medicines in Bangladesh — they should be started, and the dose adjusted, by a doctor based on your individual risk and lab results, not self-selected from a pharmacy counter.

How and when to take a statin

A few practical details affect how well a statin works and how safely you take it:

• Timing: Older, shorter-acting statins such as simvastatin were traditionally recommended for nighttime dosing, because the liver produces most of its cholesterol overnight. Atorvastatin and rosuvastatin have longer half-lives, so morning or evening dosing works about equally well — the more important habit is taking it at the same time every day, since consistency matters more than the exact hour.
• Food: Most statins can be taken with or without food; follow the instructions on your specific product's packaging.
• Grapefruit: This is a genuine interaction, not a myth — but it depends on which statin you take. Grapefruit and grapefruit juice block a liver enzyme (CYP3A4) that breaks down atorvastatin, simvastatin, and lovastatin, which can raise blood levels of the drug and the risk of side effects. Rosuvastatin, pravastatin, fluvastatin, and pitavastatin are metabolized differently and are generally considered safe with grapefruit. If you are on atorvastatin or simvastatin and enjoy grapefruit regularly, ask your doctor or pharmacist whether you should switch or avoid it.

Side effects: what is common, and what is rare

Statins have a reputation for causing muscle pain, and this deserves an honest, specific answer rather than either dismissal or alarm.

• Muscle aches or weakness are reported by up to around 1 in 10 people taking a statin in real-world use. In most cases, blood tests of muscle enzymes come back normal, and many people who switch to a different statin or a lower dose tolerate it fine.
• True statin-induced muscle disease (myopathy) — where a muscle enzyme called creatine kinase (CK) is genuinely elevated — is far less common, affecting roughly 1 in 1,000 to 1 in 10,000 users.
• Rhabdomyolysis, a severe and dangerous breakdown of muscle tissue, is rare, occurring in only a few cases per million people on statins. Risk rises with higher doses, older age, female sex, untreated hypothyroidism, kidney disease, and combining statins with certain other drugs (such as gemfibrozil or some antibiotics and antifungals).

The practical takeaway: mild muscle soreness is common and usually not dangerous, but you should contact a doctor promptly if you develop severe, unexplained muscle pain or weakness, especially together with fever, general illness, or unusually dark (tea- or cola-colored) urine — these can signal the rarer, more serious reaction and warrant an urgent CK test.

Liver effects: Standard practice is to check liver enzymes before starting a statin and again around 8–12 weeks later. If these are normal, routine repeat liver testing usually isn't needed afterward, since statins are not linked to a meaningfully increased risk of liver failure in people without pre-existing severe liver disease. Mild, temporary enzyme elevations usually don't require stopping the drug; a doctor will advise if yours is significant enough to warrant a dose change.

Blood sugar: Statins carry a modest, well-documented association with a slightly increased risk of developing type 2 diabetes, particularly in people who already have pre-diabetes risk factors. One Australian cohort study found this effect was more pronounced in women over 75, with risk rising further at higher statin doses. For most people, the cardiovascular protection statins provide still outweighs this risk — but it is a reasonable topic to discuss with your doctor, especially if you are an older adult or already borderline for diabetes, since periodic blood sugar monitoring may be advised.

Special situations

• Pregnancy: Statins are generally avoided during pregnancy. Older case reports raised concerns about effects on fetal development, and most guidelines still advise stopping statins before conception or as soon as pregnancy is confirmed, except in specific high-risk cardiovascular situations where a specialist may judge the benefit outweighs the risk. Any decision here should be made jointly with an obstetrician and cardiologist — never on your own.
• Older adults (especially over 75): Statins can still be appropriate, particularly for secondary prevention, but doctors often weigh the modestly higher risks of muscle symptoms and new-onset diabetes in this age group against the benefit, and may choose a lower dose.
• Children: Statins are occasionally used in children with inherited familial hypercholesterolemia, but only under specialist (pediatric lipid/cardiology) supervision — never started independently.
• Kidney or existing liver disease: These conditions don't automatically rule out statin use, but they do change dose selection and monitoring, so they must be disclosed to your prescribing doctor.

Can you stop taking a statin once your cholesterol looks normal?

This is one of the most common questions, and the honest answer is: not on your own, and not without rechecking first. If you have established heart disease or have had a prior heart attack or stroke, stopping a statin carries a real risk of your cardiovascular risk rebounding, even if a recent lipid panel looked good — the "normal" number may be a direct result of the medicine, not a sign you no longer need it.

Diet, weight loss, and regular exercise can meaningfully lower cholesterol, but for most people they don't match the speed or strength of a statin's effect on LDL. Some people — particularly those on a statin purely for borderline risk rather than established disease — may be able to reduce or stop their dose under medical supervision if sustained lifestyle changes bring their numbers to target and their doctor reassesses their overall risk. The key phrase in both directions is "under medical supervision": this is a decision for a follow-up lipid panel and a conversation with your doctor, not a unilateral choice.

Statins are a complement to lifestyle change, not a replacement for it

Even when a statin is clearly needed, it works best alongside the same habits that help everyone's heart: reducing saturated fat and ultra-processed food, increasing fiber (vegetables, lentils, whole grains — all accessible in a typical Bangladeshi diet), regular physical activity, maintaining a healthy weight, not smoking, and controlling blood pressure and blood sugar if you have diabetes or hypertension. A statin lowers your LDL number; lifestyle changes lower your overall cardiovascular risk from several directions at once, and the two together outperform either alone.

When to see a doctor

• Before starting any statin — to confirm you actually need one based on a proper risk assessment, not just a cholesterol number.
• If you develop severe muscle pain, weakness, dark urine, or unusual fatigue while on treatment.
• Before stopping a statin, especially if you have known heart disease, diabetes, or have had a stroke or heart attack.
• For periodic follow-up lipid panels and, where relevant, liver enzyme or blood sugar checks, on the schedule your doctor recommends.

Sources: Guidance referenced from the American College of Cardiology (ACC) and American Heart Association (AHA) cholesterol management guidelines, the World Health Organization (WHO) STEPS Bangladesh survey data, and general clinical references on statin safety and monitoring.